BioSante Pharmaceuticals, Inc.
12Patents
8Active
12Granted
45Portfolio score
Filing activity: Jun 11, 1999 → Jul 19, 2010 · 8 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8287856B2 | PD-1 antibodies in combination with a cytokine-secreting cell and methods of use thereof | Human Necessities | 48 | Active |
| US6183803A | Method for processing milk | Human Necessities | 32 | Expired |
| US6355271B1 | Therapeutic calcium phosphate particles and methods of manufacture and use | Emerging Cross-Sectional Technologies | 30 | Expired |
| US7709224B2 | Compositions and methods for enhanced expression of recombinant polypeptides from a single vector using a peptide cleavage site | Chemistry; Metallurgy | 16 | Expired |
| US7919079B2 | Cancer immunotherapy compositions and methods of use | Human Necessities | 13 | Active |
| US7714119B2 | AAV vector compositions and methods for enhanced expression of immunoglobulins using the same | Chemistry; Metallurgy | 10 | Expired |
| US7662623B2 | Compositions and methods for enhanced expression of recombinant polypeptides from a single vector using a peptide cleavage site | Chemistry; Metallurgy | 9 | Active |
| US7858083B2 | Pan cancer oncolytic vectors and methods of use thereof | Chemistry; Metallurgy | 4 | Active |
| US7632509B2 | Methods to express recombinant proteins from lentiviral vectors | Chemistry; Metallurgy | 3 | Active |
| US7939271B2 | Methods and compositions for identifying prostate cancer or a humoral immune response against prostate cancer | Physics | 2 | Active |
| US7901902B2 | Methods and compositions for identifying a cellular immune response against prostate cancer | Human Necessities | 2 | Active |
| US7645587B2 | Cancer-associated antigens and methods of their identification and use | Physics | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.